v3.26.1
Assets Held for Sale and Divestiture (Tables)
12 Months Ended
May 31, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Major Classes of Assets and Liabilities Held for Sale

The major classes of assets and liabilities held for sale of the Genomics business were as follows:

 

 

May 31, 2026

 

Accounts receivable, net

$

3.8

 

Inventory, net

 

10.3

 

Prepaid expenses and other current assets

 

1.5

 

Property and equipment, net

 

20.1

 

Right of use assets

 

0.9

 

Goodwill

 

19.4

 

Amortizable intangible assets, net

 

7.9

 

Other non-current assets

 

4.1

 

Total assets held for sale

$

68.0

 

 

 

 

Accounts payable

$

0.9

 

Accrued compensation

 

2.0

 

Other liabilities

 

3.7

 

Total liabilities held for sale

$

6.6